Canopy Growth (CGC) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
CGC slides 3.1% to $0.71, a 52-week low. Closed at $0.71, -3.13% vs the prior close of $0.74. Day range $0.70–$0.76, opened at $0.75.
CGC daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — CGC slides 3.1% to $0.71, a 52-week low
- Closed at $0.71, -3.13% vs the prior close of $0.74. Day range $0.70–$0.76, opened at $0.75.
- Volume was 2.36M shares, 0.8x its 50-day average of 3.12M.
- Price is -23.8% vs its 50-day average ($0.94) and -30.5% vs its 200-day average ($1.03).
- 52-week range $0.69–$2.38; today's close sits at 1% of that range, 70.0% below the 52-week high.
Oct 15, 2026 — CGC rises 2.9% to $0.74
- Closed at $0.74, +2.94% vs the prior close of $0.71. Day range $0.69–$0.74, opened at $0.70.
- Volume was 2.94M shares, 1.0x its 50-day average of 3.09M.
- Price is -21.7% vs its 50-day average ($0.94) and -28.5% vs its 200-day average ($1.03).
- 52-week range $0.69–$2.38; today's close sits at 3% of that range, 69.1% below the 52-week high.
Oct 14, 2026 — CGC slides 6.3% to $0.71, a 52-week low
- Closed at $0.71, -6.29% vs the prior close of $0.76. Day range $0.71–$0.76, opened at $0.76.
- Volume was 4.54M shares, 1.5x its 50-day average of 3.04M.
- Price is -24.3% vs its 50-day average ($0.94) and -30.7% vs its 200-day average ($1.03).
- 52-week range $0.71–$2.38; today's close sits at 0% of that range, 70.0% below the 52-week high.
Oct 13, 2026 — CGC rises 0.7% to $0.76
- Closed at $0.76, +0.66% vs the prior close of $0.76. Day range $0.74–$0.79, opened at $0.76.
- Volume was 3.67M shares, 1.2x its 50-day average of 3.03M.
- Price is -19.6% vs its 50-day average ($0.95) and -26.2% vs its 200-day average ($1.03).
- 52-week range $0.74–$2.38; today's close sits at 1% of that range, 67.9% below the 52-week high.
Oct 12, 2026 — CGC slides 8.3% to $0.76, a 52-week low, 4 down days in a row
- Closed at $0.76, -8.34% vs the prior close of $0.83. Day range $0.74–$0.85, opened at $0.85.
- Volume was 5.33M shares, 1.8x its 50-day average of 2.96M.
- Price is -20.4% vs its 50-day average ($0.95) and -26.9% vs its 200-day average ($1.04).
- 52-week range $0.74–$2.38; today's close sits at 1% of that range, 68.2% below the 52-week high.
- That makes 4 straight losses.
Oct 9, 2026 — CGC dips 2.4% to $0.83, a 52-week low, 3 down days in a row
- Closed at $0.83, -2.36% vs the prior close of $0.85. Day range $0.82–$0.86, opened at $0.86.
- Volume was 2.37M shares, 0.8x its 50-day average of 2.96M.
- Price is -13.5% vs its 50-day average ($0.96) and -20.4% vs its 200-day average ($1.04).
- 52-week range $0.81–$2.38; today's close sits at 1% of that range, 65.3% below the 52-week high.
- That makes 3 straight losses.
Oct 8, 2026 — CGC slides 3.4% to $0.85, a 52-week low
- Closed at $0.85, -3.42% vs the prior close of $0.88. Day range $0.81–$0.88, opened at $0.87.
- Volume was 4.17M shares, 1.4x its 50-day average of 2.94M.
- Price is -11.5% vs its 50-day average ($0.96) and -18.7% vs its 200-day average ($1.04).
- 52-week range $0.81–$2.38; today's close sits at 2% of that range, 64.4% below the 52-week high.
Oct 7, 2026 — CGC dips 1.6% to $0.88
- Closed at $0.88, -1.57% vs the prior close of $0.89. Day range $0.86–$0.89, opened at $0.89.
- Volume was 1.25M shares, 0.4x its 50-day average of 2.97M — lighter than usual.
- Price is -8.5% vs its 50-day average ($0.96) and -16.1% vs its 200-day average ($1.05).
- 52-week range $0.84–$2.38; today's close sits at 2% of that range, 63.2% below the 52-week high.
Oct 6, 2026 — CGC rises 0.7% to $0.89
- Closed at $0.89, +0.68% vs the prior close of $0.88. Day range $0.88–$0.90, opened at $0.90.
- Volume was 1.57M shares, 0.5x its 50-day average of 2.99M — lighter than usual.
- Price is -7.1% vs its 50-day average ($0.96) and -15.1% vs its 200-day average ($1.05).
- 52-week range $0.84–$2.38; today's close sits at 3% of that range, 62.6% below the 52-week high.
Oct 5, 2026 — CGC rises 1.1% to $0.88
- Closed at $0.88, +1.14% vs the prior close of $0.88. Day range $0.87–$0.90, opened at $0.88.
- Volume was 1.72M shares, 0.6x its 50-day average of 2.98M — lighter than usual.
- Price is -7.7% vs its 50-day average ($0.96) and -16.1% vs its 200-day average ($1.05).
- 52-week range $0.84–$2.38; today's close sits at 3% of that range, 62.8% below the 52-week high.
Oct 2, 2026 — CGC dips 0.8% to $0.88, a 6-month low, 5 down days in a row
- Closed at $0.88, -0.79% vs the prior close of $0.88. Day range $0.87–$0.90, opened at $0.90.
- Volume was 2.04M shares, 0.7x its 50-day average of 3.01M.
- Price is -8.8% vs its 50-day average ($0.96) and -17.4% vs its 200-day average ($1.06).
- 52-week range $0.84–$2.38; today's close sits at 2% of that range, 63.2% below the 52-week high.
- That makes 5 straight losses.
CGC latest news & SEC filings
Every SEC filing by or about CGC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Oct 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Oct 6, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Sep 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Yanofsky Theresa sold 14,920 shares at $0.93 (≈$13.83K) on Sep 28, 2026; now holds 131,495
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Lazzarato David Angelo sold 22,380 shares at $0.93 (≈$20.74K) on Sep 28, 2026; now holds 189,479
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Bayern Joseph sold 3,096 shares at $0.93 (≈$2.87K) on Sep 28, 2026; now holds 142,031
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Atkins M Shan sold 3,096 shares at $0.93 (≈$2.87K) on Sep 28, 2026; now holds 143,421
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 25, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Sep 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Stewart Thomas Carlton sold 25,755 shares at $0.93 (≈$23.95K) on Sep 17, 2026; now holds 588,412
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 15, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Aug 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Gedeon Christelle sold 13,344 shares at $1.47 (≈$19.62K) on Aug 24, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 17, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Aug 14, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Aug 7, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Aug 7, 2026 · Form ARS — Annual report to shareholders
Annual report to shareholders
Things to know before you trade CGC
- Last results release: Aug 7, 2026 (8-K Item 2.02). Previous ones: Jun 15, 2026, Feb 6, 2026, Nov 7, 2025. Based on that rhythm, the next report is likely around Nov 6, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.45% (largest 8.3%).
- Liquidity: about 2.69M shares (≈$1.92M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.71 vs a range of $0.69–$2.38 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: David Angelo Lazzarato sold 22,380 shares on Sep 28, 2026.
- Latest filings: 8-K Oct 16, 2026; 8-K Aug 7, 2026; 8-K Aug 7, 2026.
- Share count: 423.04M shares outstanding (Aug 5, 2026), +76.4% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Medicinal Chemicals & Botanical Products.
CGC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.75 | 0.76 | 0.70 | 0.71 | 2.36M |
| Oct 15, 2026 | 0.70 | 0.74 | 0.69 | 0.74 | 2.95M |
| Oct 14, 2026 | 0.76 | 0.76 | 0.71 | 0.71 | 4.54M |
| Oct 13, 2026 | 0.76 | 0.79 | 0.74 | 0.76 | 3.67M |
| Oct 12, 2026 | 0.85 | 0.85 | 0.74 | 0.76 | 5.33M |
| Oct 9, 2026 | 0.86 | 0.86 | 0.82 | 0.83 | 2.37M |
| Oct 8, 2026 | 0.87 | 0.88 | 0.81 | 0.85 | 4.17M |
| Oct 7, 2026 | 0.89 | 0.89 | 0.86 | 0.88 | 1.25M |
| Oct 6, 2026 | 0.90 | 0.90 | 0.88 | 0.89 | 1.57M |
| Oct 5, 2026 | 0.88 | 0.90 | 0.87 | 0.88 | 1.72M |
| Oct 2, 2026 | 0.90 | 0.90 | 0.87 | 0.88 | 2.04M |
| Oct 1, 2026 | 0.90 | 0.91 | 0.86 | 0.88 | 3.15M |
| Sep 30, 2026 | 0.92 | 0.92 | 0.88 | 0.90 | 3.97M |
| Sep 29, 2026 | 0.93 | 0.94 | 0.93 | 0.93 | 1.11M |
| Sep 28, 2026 | 0.94 | 0.95 | 0.93 | 0.93 | 1.48M |
| Sep 25, 2026 | 0.94 | 0.95 | 0.93 | 0.94 | 1.06M |
| Sep 24, 2026 | 0.94 | 0.95 | 0.93 | 0.93 | 1.51M |
| Sep 23, 2026 | 0.97 | 0.97 | 0.94 | 0.94 | 2.16M |
| Sep 22, 2026 | 0.93 | 0.98 | 0.92 | 0.97 | 5.36M |
| Sep 21, 2026 | 0.92 | 0.94 | 0.92 | 0.92 | 2.09M |
About Canopy Growth
Canopy Growth (CGC) is listed on the Nasdaq and classified by the SEC under “Medicinal Chemicals & Botanical Products”. Its business address is in SMITH FALLS, Ontario, Canada. State of incorporation: Canada (Federal Level). Fiscal year ends March 31. SEC CIK 1737927.
CGC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| M Shan Atkins | Director | Sep 30, 2026 |
| Joseph Bayern | Director | Sep 30, 2026 |
| David Angelo Lazzarato | Director | Sep 30, 2026 |
| Luc Mongeau | Chief Executive Officer | Jun 22, 2026 |
| Theresa Yanofsky | Director | Sep 30, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Christelle Gedeon | See Remarks | Aug 25, 2026 |
| Luc Mongeau | Chief Executive Officer | Jun 22, 2026 |
| Thomas Carlton Stewart | See Remarks | Sep 17, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 28, 2026 | David Angelo Lazzarato | Sale | 22,380 | $0.93 |
| Sep 28, 2026 | David Angelo Lazzarato | Sale | 22,380 | $0.93 |
| Sep 28, 2026 | David Angelo Lazzarato | Sale | 22,380 | $0.93 |
| Sep 28, 2026 | David Angelo Lazzarato | Sale | 22,380 | $0.93 |
| Sep 28, 2026 | Joseph Bayern | Sale | 3,096 | $0.93 |
| Sep 28, 2026 | Joseph Bayern | Sale | 3,096 | $0.93 |
| Sep 28, 2026 | Joseph Bayern | Sale | 3,096 | $0.93 |
| Sep 28, 2026 | Joseph Bayern | Sale | 3,096 | $0.93 |
| Sep 28, 2026 | Theresa Yanofsky | Sale | 14,920 | $0.93 |
| Sep 28, 2026 | Theresa Yanofsky | Sale | 14,920 | $0.93 |
| Sep 28, 2026 | Theresa Yanofsky | Sale | 14,920 | $0.93 |
| Sep 28, 2026 | Theresa Yanofsky | Sale | 14,920 | $0.93 |
| Sep 28, 2026 | M Shan Atkins | Sale | 3,096 | $0.93 |
| Sep 28, 2026 | M Shan Atkins | Sale | 3,096 | $0.93 |
| Sep 28, 2026 | M Shan Atkins | Sale | 3,096 | $0.93 |
CGC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Mar 31, 2026 | $284.60M | $-262.91M | -0.88 | $-63.81M |
| Mar 31, 2025 | $269.00M | $-508.88M | -4.73 | $-165.75M |
| Mar 31, 2024 | $297.15M | $-693.68M | -9.27 | $-281.95M |
| Mar 31, 2023 | $333.25M | $-3.28B | -70.69 | $-557.55M |
| Mar 31, 2022 | $475.70M | $-310.04M | -7.92 | $-545.81M |
Latest balance sheet: total assets $1.10B, total liabilities $415.29M, cash $336.62M (as of Jun 30, 2026).
CGC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 7, 2026 | 8-K Item 2.02 (results) | $0.97 |
| Jun 15, 2026 | 8-K Item 2.02 (results) | $0.98 |
| Feb 6, 2026 | 8-K Item 2.02 (results) | $1.10 |
| Nov 7, 2025 | 8-K Item 2.02 (results) | $1.17 |
| Aug 8, 2025 | 8-K Item 2.02 (results) | $1.25 |
| May 30, 2025 | 8-K Item 2.02 (results) | $1.32 |
| Feb 7, 2025 | 8-K Item 2.02 (results) | $2.02 |
| Nov 8, 2024 | 8-K Item 2.02 (results) | $4.24 |
| Aug 9, 2024 | 8-K Item 2.02 (results) | — |
| May 30, 2024 | 8-K Item 2.02 (results) | — |
| Feb 9, 2024 | 8-K Item 2.02 (results) | — |
| Nov 9, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Medicinal Chemicals & Botanical Products
Definium Therapeutics (DFTX)Trulieve Cannabis (TRLV)Tilray Brands (TLRY)IM Cannabis (IMCC)Glass House Brands (GLAS)Aurora Cannabis (ACB)Cronos (CRON)Usana Health Sciences (USNA)Regencell Bioscience (RGC)Sndl (SNDL)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on CGC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.